James Bligh serves as Executive at CONDUIT PHARMACEUTICALS INC., where they oversee executive responsibilities. Since joining the company, James Bligh has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 19, 2025 involved receiving (via award) 480,000 shares valued at $0.
James Bligh currently holds 480,024 shares of CONDUIT PHARMACEUTICALS INC. (CDT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Bligh has been a net neutral trader of CDT stock. They have purchased $0 and sold $0 worth of shares.
James Bligh's most recent insider trade was on Sep 19, 2025, when they sold 480,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |